Adjuvant treatment in breast cancer. Ii
García-Conde, D.J.
Chemioterapia International Journal of the Mediterranean Society of ChemoTherapy 6(2 Suppl): 711
1987
ISSN/ISBN: 0392-906X PMID: 3509527 Document Number: 298723
Document emailed within 1 workday
Related Documents
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-27122004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Zumoff, B. 1992: Adjuvant treatment in breast cancer Lancet 339(8790): 423-424
Cottu, P. 2013: Breast cancer adjuvant endocrine treatment La Revue du Praticien 63(10): 1404-1407
Russell, I.S. 1977: Adjuvant chemotherapy in the treatment of breast cancer Australian Family Physician 6(6): 629-635
Harmer, V. 2000: Adjuvant treatment for breast cancer patients Nursing Times 96(49): 34-35
O'Brien, P.H. 1976: Adjuvant treatment in operable breast cancer Journal of the South Carolina Medical Association 72(5): 173-174
Hess, C.F.; Schmidberger, H. 1998: Adjuvant radiotherapy in the treatment of breast cancer Anticancer Research 18(3c): 2213-2214
Levitt, S.H. 1995: The role of adjuvant therapy in the treatment of breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(11): 661-662
Barginear, M.F.; Van Poznak, C. 2010: Bisphosphonates: do we know their role in adjuvant breast cancer treatment? Oncology 24(6): 475; 478, 480
Merkel, D.E.; Osborne, C.K. 1989: Adjuvant treatment of node-negative breast cancer Texas Medicine 85(1): 32-36
Rossi, A.; Valagussa, P.; Bonadonna, G. 1977: Surgery and adjuvant chemotherapy in the treatment of operable breast cancer Progress in Clinical and Biological Research 12: 391-404
Kanaev, S.V.; Semiglazov, V.F.; Bugrova, I.L.; Vlasov, A.N. 1999: Effectiveness of adjuvant radiotherapy in the conservative treatment of early breast cancer Voprosy Onkologii 45(5): 511-515
Wendt, A.G.; Jones, S.E.; Salmon, S.E. 1980: Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy Cancer Treatment Reports 64(2-3): 269-273
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
2006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597